Clinical trial
Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse…
NCT00001237 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001237 |
|---|---|
| Title | Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas |
| Official title | Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Burkitt Lymphoma, Lymphoma, Large-Cell, Diffuse, Small Noncleaved-Cell |
| Intervention type | Drug |
| Interventions | granulocyte-macrophage colony stimulating factor (GM-CSF) |
| Enrollment | 120 |
| Start date | Mar 1, 1989 |
| Completion | Apr 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: